Biotech RadarJobs updated

COMPANY

Uvax Bio

uvaxbio.com ↗

Clinical Phase 1

Profile checked Oct 10, 2026

Keywords: AIDS/HIV - RelatedDisease Associated With AIDS Vaccine-Preventable Diseases HIV Infections UVAX-1107 UVAX-1197

1Trials (company is sponsor)

Timeline

  1. Trial start Early phase 1: Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25- source ↗

Clinical trials (lead sponsor) 1

RecordTitlePhaseStatusStartPrimary completion
NCT06541093Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.Early phase 1CompletedJan 30, 2024Mar 21, 2025 (actual)
Feedback